Vanguard Personalized Indexing Management LLC grew its stake in shares of The Charles Schwab Co. (NYSE:SCHW – Free Report) by 8.7% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 109,813 shares of the financial services provider’s stock after purchasing an additional 8,824 shares during the period. Vanguard Personalized Indexing Management LLC’s holdings in Charles Schwab were worth $7,985,000 as of its most recent SEC filing.
Other hedge funds have also modified their holdings of the company. Morningstar Investment Services LLC lifted its holdings in shares of Charles Schwab by 98.0% during the fourth quarter. Morningstar Investment Services LLC now owns 4,691,362 shares of the financial services provider’s stock valued at $326,284,000 after purchasing an additional 2,322,156 shares during the last quarter. M&G Plc acquired a new position in Charles Schwab during the first quarter valued at $11,452,000. Daiwa Securities Group Inc. raised its position in Charles Schwab by 10.4% during the first quarter. Daiwa Securities Group Inc. now owns 190,597 shares of the financial services provider’s stock valued at $13,788,000 after buying an additional 17,925 shares during the period. Wedmont Private Capital raised its position in Charles Schwab by 12.2% during the first quarter. Wedmont Private Capital now owns 13,130 shares of the financial services provider’s stock valued at $949,000 after buying an additional 1,430 shares during the period. Finally, Bridgewater Associates LP raised its position in Charles Schwab by 217.8% during the fourth quarter. Bridgewater Associates LP now owns 194,339 shares of the financial services provider’s stock valued at $13,371,000 after buying an additional 133,186 shares during the period. 84.38% of the stock is owned by hedge funds and other institutional investors.
Charles Schwab Price Performance
Shares of NYSE:SCHW opened at $63.84 on Wednesday. The business has a 50 day moving average price of $64.93 and a 200 day moving average price of $70.03. The Charles Schwab Co. has a twelve month low of $48.66 and a twelve month high of $79.49. The company has a market cap of $113.46 billion, a price-to-earnings ratio of 26.71, a PEG ratio of 1.16 and a beta of 0.97. The company has a quick ratio of 0.42, a current ratio of 0.42 and a debt-to-equity ratio of 0.65.
Charles Schwab Dividend Announcement
The business also recently announced a quarterly dividend, which was paid on Friday, August 23rd. Stockholders of record on Friday, August 9th were issued a $0.25 dividend. The ex-dividend date was Friday, August 9th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 1.57%. Charles Schwab’s payout ratio is presently 41.84%.
Insider Transactions at Charles Schwab
In related news, Director Carolyn Schwab-Pomerantz sold 9,000 shares of the firm’s stock in a transaction on Friday, July 19th. The stock was sold at an average price of $61.96, for a total transaction of $557,640.00. Following the completion of the sale, the director now directly owns 567,057 shares of the company’s stock, valued at approximately $35,134,851.72. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In other Charles Schwab news, CEO Walter W. Bettinger bought 25,000 shares of the stock in a transaction on Wednesday, July 17th. The stock was purchased at an average price of $66.26 per share, with a total value of $1,656,500.00. Following the acquisition, the chief executive officer now owns 827,377 shares of the company’s stock, valued at $54,822,000.02. The purchase was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Carolyn Schwab-Pomerantz sold 9,000 shares of Charles Schwab stock in a transaction on Friday, July 19th. The stock was sold at an average price of $61.96, for a total transaction of $557,640.00. Following the sale, the director now directly owns 567,057 shares of the company’s stock, valued at approximately $35,134,851.72. The disclosure for this sale can be found here. In the last ninety days, insiders sold 99,636 shares of company stock valued at $6,533,064. Corporate insiders own 6.60% of the company’s stock.
Wall Street Analyst Weigh In
Several research analysts have weighed in on the company. Keefe, Bruyette & Woods reaffirmed an “outperform” rating and issued a $80.00 target price on shares of Charles Schwab in a research report on Thursday, August 22nd. JMP Securities dropped their target price on Charles Schwab from $85.00 to $82.00 and set a “market outperform” rating on the stock in a research report on Tuesday, July 23rd. JPMorgan Chase & Co. dropped their target price on Charles Schwab from $82.00 to $78.00 and set an “overweight” rating on the stock in a research report on Wednesday, July 17th. Morgan Stanley dropped their target price on Charles Schwab from $71.00 to $70.00 and set an “equal weight” rating on the stock in a research report on Friday, August 16th. Finally, Barclays dropped their target price on Charles Schwab from $77.00 to $68.00 and set an “equal weight” rating on the stock in a research report on Wednesday, July 17th. Three research analysts have rated the stock with a sell rating, seven have assigned a hold rating and seven have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $73.75.
Read Our Latest Stock Analysis on Charles Schwab
Charles Schwab Company Profile
The Charles Schwab Corporation, together with its subsidiaries, operates as a savings and loan holding company that provides wealth management, securities brokerage, banking, asset management, custody, and financial advisory services in the United States and internationally. The company operates in two segments, Investor Services and Advisor Services.
Featured Articles
- Five stocks we like better than Charles Schwab
- Energy and Oil Stocks Explained
- Seize the Opportunity: Beyond Meat’s New Steak Could Spark Growth
- How to Read Stock Charts for Beginners
- Galmed Pharmaceuticals Surges 400%: What’s Behind the Explosion?
- About the Markup Calculator
- Gold Hits New All-Time Highs: 3 Stocks to Ride the Surge
Want to see what other hedge funds are holding SCHW? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Charles Schwab Co. (NYSE:SCHW – Free Report).
Receive News & Ratings for Charles Schwab Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Charles Schwab and related companies with MarketBeat.com's FREE daily email newsletter.